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Giant cell arteritis manifesting as mesenteric
ischemia
David Clay Evans, BS,a Michael P. Murphy, MD,a,* and Jeffrey H. Lawson, MD, PhD,a,b Durham, NC
We report a case of giant cell arteritis in an 80-year-old woman who presented with chronic mesenteric ischemia to our
vascular surgery service. Computed tomography, arteriography, and magnetic resonance angiography revealed long,
smooth stenosis of the superiormesenteric artery and focal stenosis of the celiac artery. After the patient was found to have
an elevated erythrocyte sedimentation rate and a positive temporal artery biopsy specimen, glucocorticoid therapy was
initiated. Giant cell arteritis is a rare and easily overlooked cause of vascular insufficiency that can result in a devastating
clinical outcome if not recognized before surgical therapy or other interventions are attempted. (J Vasc Surg 2005;42:
1019-22.)Giant cell arteritis is a rare and easily overlooked cause
of vascular insufficiency that can result in a devastating
clinical outcome if not recognized before surgical therapy
or other interventions are attempted. We report a case of
giant cell arteritis in patient who presented with chronic
mesenteric ischemia to our vascular surgery service.
CASE REPORT
An 80-year-old Caucasian woman presented to her physician
with 3 months of postprandial abdominal pain and cramping, a
40-lb weight loss over 3 to 6 months, progressive phagophobia
and nausea, and 4 days of new-onset constipation. She underwent
computed tomography (CT) scan with contrast 2 weeks earlier at
another hospital that revealed possible superior mesenteric artery
(SMA) stenosis (Fig 1, E). A mesenteric duplex ultrasound scan at
that time demonstrated velocities2.80 m/s in the celiac axis and
proximal SMA that suggested stenosis of 70% in both.
The patient’s past medical history was significant for diabetes
mellitus type II, hypertension, and paroxysmal atrial fibrillation.
The patient reported that her jaw tired easily when chewing, but
denied any headache, recent changes in vision, or constitutional
symptoms including fever and night sweats. She denied joint pain
and stiffness except in her neck where she previously underwent
cervical spine fusion. The review of systems was otherwise unre-
markable.
On physical examination, her abdomen was soft, nontender,
and nondistended with active bowel sounds. Cardiac and vascular
exams were normal with 2 radial, brachial, femoral, popliteal,
posterior tibial, dorsalis pedis, and carotid pulses, and no carotid or
abdominal bruits. Right arm blood pressure was 196/77 and left
arm blood pressure was 213/97. The temporal arteries were not
palpable or tender. Specimens from a colonoscopy with random
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ischemia, or other pathologies. She was referred to the Vascular
Surgery Service at Duke University Medical Center for further
evaluation of her mesenteric vascular symptoms and possible sur-
gical revascularization.
Laboratory data on admission included normal chemistries
and liver function test results, a hematocrit of 40%, mean corpus-
cular volume of 75, white blood cell count of 7.6  103, and a
platelet count of 359/mm3. The erythrocyte sedimentation rate
(ESR) was 45 mm/h (reference range, 0 to 15 mm/h). C-reactive
protein (CRP) was 4.98 mg/dL (reference range, 0.6 mg/dL).
Albumin was 2.9 g/dL (reference range, 3.9 to 5.0 g/dL), and
prealbumin was 11.9 mg/dL (reference range, 18 to 45 mg/dL).
A mesenteric arteriogram demonstrated a mild stenosis of the
celiac axis and a long smooth segment of proximal SMA with
diffuse disease suggestive of vasculitis (Fig 1, A to D). Abdominal
and pelvic magnetic resonance angiography (MRA), with and
without contrast, was obtained using standard pulse sequences
(Fig 1, F). MRA was repeated using cardiovascular MRI pulse
sequences (Fig 1, G), revealing a proximal 90% stenosis in the
superior mesenteric artery and 75% stenosis of the celiac artery at its
origin.
Results of a temporal artery biopsy were consistent with giant
cell arteritis (Fig 2). The patient was prescribed 60 mg of pred-
nisone daily, with no immediate relief of symptoms. After 26 days
of hospitalization, the patient was discharged home on oral ste-
roids and encouraged to take multiple small meals each day.
In the following 2 months the patient experienced continued
but improving nausea and abdominal pain along with a further
40-lb weight loss. By 3 months, she was able to tolerate small
meals. Her symptoms completely resolved by 6 months, and her
ESR returned to baseline as she began to regain weight. By 21
months after her original hospitalization, she had regained 50 lbs
and underwent repeat MRA scanning that showed complete reso-
lution of her SMA stenosis (Fig 3). Her prednisone is slowly being
tapered for eventual discontinuation.
DISCUSSION
Chronic mesenteric ischemia is a relatively uncommon
diagnosis with an annual incidence of 2 to 4 patients per
100,000 persons in Europe.1 Most reviews of mesenteric
ischemia do not mention giant cell arteritis or any of the
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written on the topic of mesenteric giant cell arteritis. The
incidence of “temporal” arteritis is 17.4/100,000 patients
50 years old and 29/100,000 patients 70 years.2 About
9% of patients with giant cell arteritis have extracranial
involvement.3
No data are available on the epidemiology of mesen-
teric ischemia caused by giant cell arteritis, but a literature
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arteritis can be elusive. The presentation of an elderly
patient with gradually worsening postprandial abdominal
pain, weight loss, and radiographic evidence of superior
mesenteric artery stenosis is typical of “intestinal angina” or
chronic mesenteric ischemia due to atherosclerosis. In cases
where mesenteric ischemia is suspected, mesenteric duplex
ultrasonography has become common for the initial screen-
ing, with reported sensitivities of 96% and 100% for 50%
stenosis of the SMA and celiac arteries, respectively.6
Because of extensive collateral circulation, mesenteric
ischemia typically requires the involvement of at least two
mesenteric vessels and 85% of cases involve both the
celiac artery and SMA. However, when the mesenteric
arteriogram reveals a long segment of smooth, diffuse
narrowing or progressive, multiple focal taperings and post-
stenotic dilatation, a diagnosis of vasculitis should be con-
sidered. A temporal artery biopsy specimen, consideration
of further imaging studies, and laboratory tests including
ESR, CRP, antinuclear antibodies (ANA), antineutrophil
cytoplasmic antibodies (ANCA), complements C3 and C4,
hepatitis B and C serologies, and urinalysis then become
necessary to confirm a diagnosis of giant cell arteritis and
exclude other vasculitides.
Much has been done to characterize giant cell arteritis.
In 1990, the American College of Rheumatology estab-
lished criteria for the diagnosis of giant cell (temporal)
arteritis. The presence of three or more of the following five
criteria is 93.5% sensitive and 91.2% specific for giant cell
arteritis: age of onset 50 years, new headache, decreased
temporal artery pulse or tenderness, ESR 50mm/hr, and
artery biopsy specimen showing vasculitis characterized by
Fig 3. Follow-up MRA obtained 21 months after initial presen-
tation demonstrates that the SMA is now grossly normal in appear-
ance, with no evidence of stenosis. The celiac artery still shows
unchanged focal 70% stenosis and poststenotic dilatation. The
inferior mesenteric artery is also now patent, with no evidence for
stenosis (not visible in this view).mononuclear cell infiltrates or granulomatous inflamma-tion and commonly, multinucleated giant cells.7 Our pa-
tient, without headache or temporal artery signs or symp-
toms, and with an ESR of 45 mm/h, did not meet these
published criteria. However, it might be reasonable to
propose that intestinal symptomsmight be considered as an
equivalent for headache for purposes of these criteria, as
both symptoms are caused by inflammation/insufficient
arterial perfusion due to the underlying disease process.
Patients with giant cell arteritis also frequently display
other vascular complications, including blindness, jaw clau-
dication, arm claudication and weak peripheral pulses.
Nonvascular, inflammation-related complications typically
include malaise, anorexia, weight loss, fever, night sweats,
and depression.
Although there is no radiologic standard for the evalu-
ation of giant cell arteritis, three-dimensional MRA using
pulse sequences used for cardiovascular imaging have pre-
viously been applied to Takayasu’s arteritis to demonstrate
thickening of the vessel wall, even when stenosis or dilata-
tion have not occurred. MRA provides better visual con-
trast and resolution for the examination of soft tissue and
can show other signs of inflammation, including mural
edema and increased mural vascularity.8 It seems reason-
able that this technology can appropriately be applied to
vasculidities of the mesenteric circulation as well and may
provide the best means of following the progression of
disease with treatment.
Despite the benefits of MRA, conventional angiogra-
phy is still necessary for visualization of distal arterial struc-
tures if revascularization is considered.9 Annual chest radi-
ography or other surveillance of patients with giant cell
arteritis is recommended; according to one study, these
patients are 17 times more likely to develop thoracic aortic
aneurysm and 2.4 times more likely to develop abdominal
aortic aneurysm than the general population.10
The gold standard treatment for giant cell arteritis is
glucocorticoid therapy. Initial doses are typically 40 to 60 mg
of prednisone daily until symptoms fully resolve and the ESR
and CRP return to normal.11 In one clinical trial, the mean
duration of treatment for giant cell arteritis was 16
months.12 Methotrexate is considered as an adjunct to
prednisone in patients when toleration of glucocorticoid
therapy is a concern. Because of the mild thrombocytosis
present in giant cell arteritis, treatment may benefit from
the addition of aspirin.
Although surgical revascularization is standard treat-
ment for chronic mesenteric ischemia, bypass grafts should
not be considered in patients with active giant cell arteritis
because they have a tendency to occlude and the properties
of inflamed tissues do not lead to an effective anastomosis.
Only in the setting of aneurysm or dissection and ideally,
after completion of steroid therapy, should surgical inter-
vention be considered.13
We thank Dr Charles Steenbergen for reviewing pa-
thology slides and facilitating use of the photopathology
and Suzanne Finley, Dr Michael Miller, and Dr Charles
Spritzer for help preparing radiographic images.
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